Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Sandoz, a division of the Novartis group, has introduced piperacillin and tazobactam for injection, a generic equivalent of Zosyn, in the US.
Subscribe to our email newsletter
Piperacillin and tazobactam for injection is an antibacterial treatment indicated for use in adults with certain types of moderate to severe infections caused by piperacillin-resistant, piperacillin/tazobactam susceptible, ß-lactamase producing strains.
Sandoz said that it is offering piperacillin and tazobactam for injection in 2.25g, 3.375g and 4.5g vials, the same standard vial strengths marketed for Zosyn.
Sandoz president Don DeGolyer said that the US launch of piperacillin and tazobactam for injection, or generic Zosyn, further strengthens their portfolio in that field.